Literature DB >> 16338858

Thermal tumour ablation: devices, clinical applications and future directions.

D Haemmerich1, P F Laeseke.   

Abstract

Tumour ablation is clinically applied mainly for non-operable liver tumours, with increasing application to other organ sites like kidney, lung, adrenal gland and bone. Most current devices use radiofrequency (RF) current to heat tumour tissue surrounding the applicator, which is introduced into the tumour under imaging guidance. Tissue temperatures in excess of 100 degrees C are achieved, with cell death due to coagulative necrosis occurring above 50 degrees C. Limitations of current ablation devices include inadequate imaging, limited size of coagulation zone and reduced performance next to large vessels. This paper reviews current interstitial RF and microwave devices, clinical applications and future research directions in the field of high-temperature tumour ablation.

Entities:  

Mesh:

Year:  2005        PMID: 16338858     DOI: 10.1080/02656730500226423

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  17 in total

1.  Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue.

Authors:  A Andreano; Yu Huang; M Franca Meloni; Fred T Lee; Christopher Brace
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

2.  Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings.

Authors:  Michael M Awad; Lara Devgan; Ihab R Kamel; Michael Torbensen; Michael A Choti
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 3.  MRI-guided focused ultrasound surgery.

Authors:  Ferenc A Jolesz
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

Review 4.  Fever and the thermal regulation of immunity: the immune system feels the heat.

Authors:  Sharon S Evans; Elizabeth A Repasky; Daniel T Fisher
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

Review 5.  Laparoscopic and image-guided radiofrequency ablation of renal tumors: patient selection and outcomes.

Authors:  Scott M Castle; Vladislav Gorbatiy; Obi Ekwenna; Raymond J Leveillee
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

6.  Nanosecond pulsed electric fields cause melanomas to self-destruct.

Authors:  Richard Nuccitelli; Uwe Pliquett; Xinhua Chen; Wentia Ford; R James Swanson; Stephen J Beebe; Juergen F Kolb; Karl H Schoenbach
Journal:  Biochem Biophys Res Commun       Date:  2006-03-10       Impact factor: 3.575

Review 7.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.

Authors:  Chitta Ranjan Patra; Resham Bhattacharya; Debabrata Mukhopadhyay; Priyabrata Mukherjee
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

8.  Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healing.

Authors:  Yoshiaki Hattori; Leo Falgout; Woosik Lee; Sung-Young Jung; Emily Poon; Jung Woo Lee; Ilyoun Na; Amelia Geisler; Divya Sadhwani; Yihui Zhang; Yewang Su; Xiaoqi Wang; Zhuangjian Liu; Jing Xia; Huanyu Cheng; R Chad Webb; Andrew P Bonifas; Philip Won; Jae-Woong Jeong; Kyung-In Jang; Young Min Song; Beatrice Nardone; Michael Nodzenski; Jonathan A Fan; Yonggang Huang; Dennis P West; Amy S Paller; Murad Alam; Woon-Hong Yeo; John A Rogers
Journal:  Adv Healthc Mater       Date:  2014-03-26       Impact factor: 9.933

9.  Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity.

Authors:  Sergio A Dromi; Meghaan P Walsh; Sarah Herby; Bryan Traughber; Jianwu Xie; Karun V Sharma; Kiran P Sekhar; Alfred Luk; David J Liewehr; Matthew R Dreher; Terry J Fry; Bradford J Wood
Journal:  Radiology       Date:  2009-02-27       Impact factor: 11.105

10.  Two-dimensional nanosecond electric field mapping based on cell electropermeabilization.

Authors:  Meng-Tse Chen; Chunqi Jiang; P Thomas Vernier; Yu-Hsuan Wu; Martin A Gundersen
Journal:  PMC Biophys       Date:  2009-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.